Fatal liver injury associated with clopidogrel |
| |
| Authors: | Sarrah Kastalli Sihem El Aïdli Ahmed Zaïem Hatem Ben Abdallah Riadh Daghfous |
| |
| Affiliation: | 1. Centre National de Pharmacovigilance, 9 Avenue du Dr. Zouheir Essafi 1006 Tunis, Tunisia;2. Department of Gastroenterology. Military Hospital, Mont Fluery 1008 Tunis, Tunisia |
| |
| Abstract: | Clopidogrel, an adenosine diphosphate receptor blocker, is widely used as an adjunctive antiplatelet therapy in acute coronary syndrome and percutaneous coronary stenting. It appears to be a safe drug with few occurrences of liver side‐effects that usually resolved after drug withdrawal. We report a serious liver injury with fatal outcome in a 63‐year‐old man developed 19 days after starting clopidogrel for percutaneous coronary stenting. |
| |
| Keywords: | adverse effect clopidogrel hepatotoxicity |
|
